flubromazolam flubromazolam flubromazolam (jyi-73) is a triazolobenzodiazepine (tbzd), which are benzodiazepine (bzd) derivatives. flubromazolam is reputed to be highly potent, and concerns have been raised that clonazolam and flubromazolam in particular may pose comparatively higher risks than other designer benzodiazepines, due to their ability to produce strong sedation and amnesia at oral doses of as little as 0.5 mg. life-threatening adverse reactions have been observed at doses of only 3 mg of flubromazolam. flubromazolamlegal statuslegal status ca: schedule iv de: anlage ii (authorized trade only, not prescriptible) uk: under psychoactive substances act us: the dea has announced intent to place flubromazolam under control in schedule i illegal in sweden and switzerland identifiers iupac name 8-bromo-6-(2-fluorophenyl)-1-methyl-4h-triazolo benzodiazepine cas number612526-40-6 ypubchem cid21930924chemspider10684757 nunii1bf1hn5gwdcomptox dashboard (epa)dtxsid40620266 chemical and physical dataformulac17h12brfn4molar mass371.213 g·mol−13d model (jsmol)interactive image smiles brc1=cc3=c(c=c1)2c(=nn=c2c)cn=c3c4=c(c=cc=c4)f inchi inchi=1s/c17h12brfn4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8h,9h2,1h3 nkey:vxgszbzqcbnuip-uhfffaoysa-n n ny (what is this?) legal status sweden flubromazolam has been classified as an illegal substance in sweden after seizures by customs and police, as well as indications from the emcdda of wider use as a recreational drug. switzerland flubromazolam is illegal in switzerland as of december 2015. united kingdom in the uk, flubromazolam has been classified as a class c drug by the may 2017 amendment to the misuse of drugs act 1971 along with several other designer benzodiazepine drugs. australia in australia, flubromazolam is schedule 9 under federal law. united states flubromazolam is controlled in virginia. in december 2022 the dea announced it might be placing flubromazolam under temporary schedule i status for 2 years starting on january 23, 2023. unless the dea submits to extend or place into permanent schedule i status this order will expire on january 23, 2025. bromazolam itself and the de-fluoro, chloro substituted analog phenazolam was not included in this emergency scheduling action.